CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells
Recent advances in cancer cell biology have focused on histone deacetylase inhibitors (HDACi’s) because they target pathways critical to the development and progression of disease. In particular, HDACi’s can induce expression of epigenetically silenced genes that promote growth arrest, differentiati...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2007-06-01
|
| Series: | Neurobiology of Disease |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996107000629 |